Literature DB >> 16282479

Characterization of adeno-associated virus genomes isolated from human tissues.

Bruce C Schnepp1, Ryan L Jensen, Chun-Liang Chen, Philip R Johnson, K Reed Clark.   

Abstract

Infection with wild-type adeno-associated virus (AAV) is common in humans, but very little is known about the in vivo biology of AAV. On a molecular level, it has been shown in cultured cells that AAV integrates in a site-specific manner on human chromosome 19, but this has never been demonstrated directly in infected human tissues. To that end, we tested 175 tissue samples for the presence of AAV DNA, and when present, examined the specific form of the viral DNA. AAV was detected in 7 of 101 tonsil-adenoid samples and in 2 of 74 other tissue samples (spleen and lung). In these nine samples, we were unable to detect AAV integration in the AAVS1 locus using a sensitive PCR assay designed to amplify specific viral-cellular DNA junctions. Additionally, we used a second complementary assay, linear amplification-mediated-PCR (LAM-PCR) to widen our search for integration events. Analysis of individual LAM-PCR products revealed that the AAV genomes were arranged predominantly in a head-to-tail array, with deletions and extensive rearrangements in the inverted terminal repeat sequences. A single AAV-cellular junction was identified from a tonsil sample and it mapped to a highly repetitive satellite DNA element on chromosome 1. Given these data, we entertained the possibility that instead of integrated forms, AAV genomes were present as extrachromosomal forms. We used a novel amplification assay (linear rolling-circle amplification) to show that the majority of wild-type AAV DNA existed as circular double-stranded episomes in our tissues. Thus, following naturally acquired infection, AAV DNA can persist mainly as circular episomes in human tissues. These findings are consistent with the circular episomal forms of recombinant AAV vectors that have been isolated and characterized from in vivo transduced tissues.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282479      PMCID: PMC1287572          DOI: 10.1128/JVI.79.23.14793-14803.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Adeno-associated virus vector integration junctions.

Authors:  E A Rutledge; D W Russell
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue.

Authors:  D Duan; P Sharma; J Yang; Y Yue; L Dudus; Y Zhang; K J Fisher; J F Engelhardt
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

3.  In vivo model of adeno-associated virus vector persistence and rescue.

Authors:  S A Afione; C K Conrad; W G Kearns; S Chunduru; R Adams; T C Reynolds; W B Guggino; G R Cutting; B J Carter; T R Flotte
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

4.  Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle.

Authors:  K R Clark; T J Sferra; P R Johnson
Journal:  Hum Gene Ther       Date:  1997-04-10       Impact factor: 5.695

Review 5.  Site-specific integration by adeno-associated virus.

Authors:  R M Linden; P Ward; C Giraud; E Winocour; K I Berns
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

6.  Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro.

Authors:  C C Yang; X Xiao; X Zhu; D C Ansardi; N D Epstein; M R Frey; A G Matera; R J Samulski
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

7.  Adenovirus-mediated gene therapy in a mouse model of hereditary tyrosinemia type I.

Authors:  K Overturf; M al-Dhalimy; C N Ou; M Finegold; R Tanguay; A Lieber; M Kay; M Grompe
Journal:  Hum Gene Ther       Date:  1997-03-20       Impact factor: 5.695

8.  A novel 165-base-pair terminal repeat sequence is the sole cis requirement for the adeno-associated virus life cycle.

Authors:  X Xiao; W Xiao; J Li; R J Samulski
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

9.  Charged-to-alanine scanning mutagenesis of the N-terminal half of adeno-associated virus type 2 Rep78 protein.

Authors:  M Urabe; Y Hasumi; A Kume; R T Surosky; G J Kurtzman; K Tobita; K Ozawa
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

10.  Human gene targeting by adeno-associated virus vectors is enhanced by DNA double-strand breaks.

Authors:  Daniel G Miller; Lisa M Petek; David W Russell
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

View more
  92 in total

1.  Recombinant adeno-associated viral vector production and purification.

Authors:  Jin-Hong Shin; Yongping Yue; Dongsheng Duan
Journal:  Methods Mol Biol       Date:  2012

Review 2.  Safe harbours for the integration of new DNA in the human genome.

Authors:  Michel Sadelain; Eirini P Papapetrou; Frederic D Bushman
Journal:  Nat Rev Cancer       Date:  2011-12-01       Impact factor: 60.716

3.  A long-term efficacy study of gene replacement therapy for RPGR-associated retinal degeneration.

Authors:  Zhijian Wu; Suja Hiriyanna; Haohua Qian; Suddhasil Mookherjee; Maria M Campos; Chun Gao; Robert Fariss; Paul A Sieving; Tiansen Li; Peter Colosi; Anand Swaroop
Journal:  Hum Mol Genet       Date:  2015-04-15       Impact factor: 6.150

Review 4.  Viral vectors for gene delivery to the central nervous system.

Authors:  Thomas B Lentz; Steven J Gray; R Jude Samulski
Journal:  Neurobiol Dis       Date:  2011-10-07       Impact factor: 5.996

Review 5.  Cardiac gene therapy.

Authors:  Antoine H Chaanine; Jill Kalman; Roger J Hajjar
Journal:  Semin Thorac Cardiovasc Surg       Date:  2010

Review 6.  Cardiac gene therapy with SERCA2a: from bench to bedside.

Authors:  Judith K Gwathmey; Alexan I Yerevanian; Roger J Hajjar
Journal:  J Mol Cell Cardiol       Date:  2010-11-18       Impact factor: 5.000

7.  Detection of a novel porcine parvovirus, PPV4, in Chinese swine herds.

Authors:  Lv Huang; Shao-Lun Zhai; Andrew K Cheung; Hong-Biao Zhang; Jin-Xue Long; Shi-Shan Yuan
Journal:  Virol J       Date:  2010-11-21       Impact factor: 4.099

8.  Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction.

Authors:  Jinhui Wang; Jing Xie; Hui Lu; Lingxia Chen; Bernd Hauck; Richard Jude Samulski; Weidong Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-30       Impact factor: 11.205

Review 9.  Barriers for retinal gene therapy: separating fact from fiction.

Authors:  Rajendra Kumar-Singh
Journal:  Vision Res       Date:  2008-06-18       Impact factor: 1.886

Review 10.  Gene therapy using adeno-associated virus vectors.

Authors:  Shyam Daya; Kenneth I Berns
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.